CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-15 | Brughera Marco Maria Director | Grant or award · Stock Option | +20,000 | $5.58 | $112K | 195,545 |
| 2024-08-15 | RALLIS CHRIS A Director | Grant or award · Stock Option | +20,000 | $5.58 | $112K | 196,658 |
| 2024-08-15 | Hackman Jeffrey S. Chief Executive Officer | Grant or award · Stock Options | +400,000 | $5.58 | $2.2M | 400,000 |
| 2024-08-01 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale | −2,431 | $6.26 | $15K | 187,471 |
| 2024-07-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,042 | 108,439 | ||
| 2024-07-31 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Grant or award | +2,431 | 189,902 | ||
| 2024-07-05 | RALLIS CHRIS A Director | Option exercise 10b5-1 | +1,792 | $2.79 | $5K | 47,630 |
| 2024-07-05 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,173 | $6.03 | $7K | 46,457 |
| 2024-07-05 | RALLIS CHRIS A Director | Option exercise · Common Shares 10b5-1 | −1,792 | $2.79 | $5K | 179,802 |
| 2024-07-02 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,431 | $6.13 | $15K | 187,471 |
| 2024-07-01 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +2,431 | 189,902 | ||
| 2024-07-01 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,042 | 107,397 | ||
| 2024-06-03 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,431 | $6.76 | $16K | 187,471 |
| 2024-05-31 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award | +1,042 | 106,355 | ||
| 2024-05-31 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Grant or award 10b5-1 | +2,431 | 189,902 | ||
| 2024-05-16 | Haigh Adrian CHIEF OPERATING OFFICER | Grant or award · Stock Option | +50,000 | 410,246 | ||
| 2024-05-16 | Haigh Adrian CHIEF OPERATING OFFICER | Grant or award · Restricted Shste Unit | +25,000 | 435,246 | ||
| 2024-05-16 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option | +200,000 | 1,755,902 | ||
| 2024-05-16 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Share Unit | +100,000 | 1,855,902 | ||
| 2024-05-16 | Andrade Robert CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +100,000 | 728,958 |
Page 13 of 17 · 340 trades